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Abstract
Objectives: Air pollution has become a critical environmental issue, which severely threatens the well-being of asthma patients. The quality of life 
of these patients, when exposed to air pollutants such as particulate matter 10 (PM10), has been poorly studied. The current research examined 
the association between the concentration of PM10 in the air and the quality of life of patients with asthma. Material and Methods: The study group 
consisted of 300 adult asthma patients treated in 2 allergy outpatient clinics in Kraków, who declared they would not leave the city in the 14-day study 
period. Daily concentrations of PM10 from air monitoring stations were recorded over a period of 2 weeks, following which the patients filled out 
the standardized Asthma Quality of Life Questionnaire (AQLQ) regarding the monitored period to assess the total quality of life and its 4 domains 
(symptoms, limitation of activity, emotional functioning and environmental stimuli). Results: The average PM10 exposure was 65.2 μg/m3 and only 30% 
of the patients were exposed to values of ≤50 μg/m3, i.e., the highest 24-h threshold value considered acceptable by the World Health Organization. 
The observed effect of an increased level of exposure to airborne PM10 was associated with reduced scores in AQLQ from 0.40 at the medium level 
to 0.46 at the high level, in comparison to the low level. The total score of the asthma-related quality of life and its domains showed poorer outcomes 
as the concentration of PM10 was increasing (every 0.08 pt per a 10 μg/m3 increase). Conclusions: The increase in the concentration of PM10 in the air 
impacts on the overall quality of life and its particular domains in people with exceptional predispositions, such as patients with bronchial asthma. 
Physicians taking care of asthma patients should pay special attention to the quality of  patient’s life in response to the course and control of that ill-
ness, in relation to air pollution. Int J Occup Med Environ Health. 2020;33(3):311–24
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INTRODUCTION
Asthma is a common chronic non-communicable disease 
that affects as many as 339 million people of all ages in 
all parts of the world, and is increasing as people adopt 
modern lifestyles and live in a more urbanized environ-
ment. With a predicted increase in the proportion of 
the world’s population living in urban areas, there is likely 
to be a significant increase in the number of people with 
asthma worldwide over the next 2 decades. It is estimated 
that there may be an additional 100 million people with 
asthma by 2025 [1,2].
Asthma causes a substantial health burden to societies, 
reducing the quality of life, not only due to physical and 
psychological health, but also due to socio-economic out-
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tic perspective, air pollutants cause oxidative injury to 
the airways, leading to inflammation, remodeling, and 
an increased risk of sensitization. Ambient levels of PM 
exacerbate existing asthma, especially by contributing to 
oxidative stress and allergic inflammation. There is also 
some evidence in support of PM as a cause of new cases 
of asthma in all populations, both children and adults [10]. 
The association between air pollution and asthma mor-
bidity is well proven. Patients with asthma living in urban 
areas with high particulate pollution levels are more likely 
to have frequent asthma symptoms, asthma-related emer-
gency department visits and hospitalizations than those 
living in areas with low pollution [11]. A systematic review 
and meta-analysis of cohort studies have proven the asso-
ciation between long-term exposure to air pollution and 
the incidence of asthma. Epidemiological studies have 
shown the impact of air pollutants on the increasing in-
cidence of asthmatic symptoms and other adverse health 
effects. These results suggest a deleterious effect of am-
bient air pollution on the incidence of asthma in adults 
[12–14].
There is epidemiological evidence that asthmatic symp-
toms can be worsened by an increase in PM10. Exposure 
to air pollution contributes to asthma development, ag-
gravations and exacerbations. Typical outdoor air pollut-
ants that can trigger asthmatic symptoms include PM, with 
the severity of symptoms varying with the level of exposure. 
An increase in air pollutants (i.e., ozone and PM) raises 
the risk of both asthma development and its symptoms.
Exposure to PM10 can trigger or exacerbate asthma at-
tacks, and control is essential for proper risk management 
and risk communication for the exposed asthma patients, 
especially those living in urban environments [15,16].
Asthma as a chronic disease could cause problems and 
difficulties in everyday functioning, in psychological 
and mental health related to the prevalence of anxi-
ety and depression symptoms, which impact on subjec-
tive health. A lot of asthma patients have screened posi-
comes. The various estimations of its economic burden, 
mostly due to productivity loss, are significant. A socio-
economic analysis for Europe reported that some 625 mil-
lion limited-activity days could be attributed to the effects 
of air pollution by ozone and particulate matter 10 (PM10) 
alone, especially among asthma patients [3,4].
Human health may be adversely affected by long-term ex-
posure to air pollution, even at relatively low concentra-
tions. Epidemiological studies of the acute effects of air 
pollution have provided evidence for increased mortality 
and morbidity associated with particulate matter (PM) 
levels, even at low or moderate concentrations [5–7].
Many epidemiological studies use the PM10 level as an 
indicator of air pollution exposure. Particulate matter 10 
represents the particle mass that enters the respiratory 
tract; moreover, it includes both coarse particles (sized 
2.5–10 μm) and fine particles (<2.5 μm, PM2.5) that are 
considered to contribute to the health effects observed 
in populations living in urban environments. Particulate 
matter contains microscopic solids or liquid droplets 
that are so small that they can be inhaled and cause se-
rious health problems. Particles of <10 μm in diameter 
pose the greatest threat, because they can get deep into 
the lungs and even the bloodstream [8]. There are nu-
merous studies on the effects of short-term exposure to 
PM10, which has been used as a basis for the development 
of the WHO Air Quality Guidelines (AQG) and interim 
targets for 24-h concentrations of PM. The health risks 
associated with short-term exposure to PM10 produce 
an increase in mortality of ca. 0.5% for each 10 μg/m3 
increment in the daily concentration. Therefore, a PM10 
concentra tion of 150 μg/m3 would be expected to trans-
late into roughly a 5% increase in daily mortality, an im-
pact that would be of significant concern, and one for 
which immediate mitigation actions would be recom-
mended [9].
Patients with asthma are one of the most at risk groups 
of morbidity caused by air pollution. From a mechanis-
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ease. The use of this questionnaire has proven that a 0.5-pt 
decrease in the total score of AQLQ is a harbinger of an 
unfavorable course of the disease [22,23].
The HRQL in patients with asthma exposed for a long 
time to air pollutants, such as PM10, in the urban environ-
ment has been poorly studied. There is little evidence that 
PM10 reduces the quality of life in asthma patients, and 
could be related to the likelihood of the initial sensitiza-
tion and induction of both the disease and syndromes. 
Only limited evidence exists on the impact of PM10 on 
the HRQL of patients with bronchial diseases. There is no 
conclusive confirmation of the unambiguously detrimental 
connection between the quality of life and the concentra-
tion of PM10 in the outdoor air. A pilot study conducted in 
2013 in Kraków, Poland, did not significantly prove the as-
sociation between PM10 concentrations in the outdoor air 
and the quality of life of asthma patients [24]. Since the as-
sessment of the impact of exposure to air pollutants, such 
as PM10, on the quality of life of patients with bronchial 
asthma has not yet been the subject of a sufficient num-
ber of studies, this study gives an additional opportunity 
to assess and discuss this problem, in order to improve 
the well-being of adult asthma patients.
The objective of the study was to assess the impact of PM10 
exposure on the quality of life of patients with asthma liv-
ing in Kraków, and to determine whether this exposure 
was related to changes in their subjective health. Results 
of this study should be important in planning preventive 
programs, risk communication and patients’ education to 
improve their well-being.
MATERIAL AND METHODS
A group of 349 adults patients (>18 years old) with mod-
erate asthma, treated in 2 allergy outpatient clinics located 
in Kraków, were recruited for a 2-year survey conducted 
in 2013–2015. These patients were with partially con-
trolled asthma, living in Kraków, and they declared not 
to leave the city during 14 days of the survey. Each pa-
tive for depressive symptoms, and they report a worse 
quality of life during control visits in the outpatient al-
lergy clinic, but it is not well confirmed by epidemiologi-
cal studies. Therefore, the asthma-related quality of life 
(ARQL) measured by disease-specific scales should also 
be considered in the assessment of the social and health 
status of these patients [17,18]. Measurements of health 
among asthma patients, and also the effects of health 
care, must include not only an indication of changes in 
the frequency and severity of asthma or its symptoms, 
but also an estimation of self-assessed well-being. This 
should be assessed by measuring the changes in the pa-
tient’s quality of life. The health-related quality of life 
(HRQL) is a broad ranging concept affected in a com-
plex way by the person’s own physical health, psychologi-
cal state and mental health, the level of independence, 
social relationships, personal health beliefs, and the rela-
tionship to the salient features of their physical environ-
ment, including air pollutants [19].
It seems that verification of the quality of life of patients 
with bronchial asthma may be as useful as routine diagnos-
tic methods that assess the disease course control.
In the asthma management and treatment process, HRQL 
is an important cause and outcome. In clinical practice, 
the assessment of the quality of life gives valuable infor-
mation that can indicate areas in which the patient is most 
affected and needs support. It helps the physician in advis-
ing and making the best choices in patient care. Surveys 
have shown that differences in assessing the quality of life 
depend on the patient’s gender and place of residence, 
which may indicate the groups to which therapeutic and 
educational efforts should be directed [20,21]. It seems 
that in assessing the impact of air pollution on asthma 
control, an analysis of the patient’s quality of life should 
be prognostic in the treatment process.
The Asthma Quality of Life Questionnaire (AQLQ) is one 
of the most popular tools used to measure changes in 
HRQL over the course of treatment of this chronic dis-
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of the quality of life for each patient. Thus, the quality of life 
for particular domains was calculated. The 4 domains dif-
fered in the number of questions, with symptoms including 
12 questions, limitation of activity – 11, emotional function-
ing – 5, and environmental stimuli – 4.
The patient’s diary was used as a next tool. Its first part was 
completed by a physician specializing in allergic diseases 
during the first visit, including the date of birth, the place of 
residence, education, employment, workplace, way to work, 
smoking, keeping pets at home, and the type of treatment 
applied. The second part was used for everyday completion 
by the patient over 2 weeks of observation. Information 
for each patient was obtained that pertained, inter alia, to 
the number of hours and places they spent outside.
For each patient, a daily concentration of PM10 on each 
day of observation, from all available air pollution moni-
toring stations of the Voivodeship Environmental Pro-
tection Inspectorate in Kraków, was reported and intro-
duced to the database. Then, the patients were assigned 
to the station which was the closest to their declared out-
door place of stay in order to determine what concentra-
tion of the PM10 fraction the patients were exposed to in 
the survey period. A selected address for each patient was 
verified and then entered into Google maps. The point 
measured on the map was determined with the command 
“measure distance.” Then, the locations for 3 stations of 
the Voivodeship Environmental Protection Inspectorate 
in Kraków were searched for and, at each, a point was 
designated by the command “distance to that place.” Data 
about PM10 concentrations recorded by particular stations 
were obtained from the webpage of the Voivodeship Envi-
ronmental Protection Inspectorate [25].
Overall, 349 patients were recruited, but 49 of them were 
eventually excluded due to leaving the city in the observa-
tion period, or not filling out/losing the patient’s diary.
Finally, data of 300 patients aged 20–80 years (average 
53±15.3 year) were used for the analysis, including 145 
women (48.3%) and 155 men (51.7%).
tient was subjected to observation for 2 weeks. The sur-
veyed patients with bronchial asthma were diagnosed ac-
cording to the applicable standards, and they were under 
permanent control of a physician specializing in allergic 
diseases. In the study group, the recruited patients were 
under regular treatment in an outpatient allergy clinic. 
The group was fairly homogenous, i.e., it included patients 
with partially controlled asthma, well educated in asthma, 
recognizing and controlling symptoms of the disease, with 
a good knowledge of the types and use of medication, and 
regularly taking their medications.
The exposure to PM10 depended on the observation pe-
riod, and the place of residence in the city district was con-
trolled and measured.
During the first visit, the patients signed an informed con-
sent form and agreed to participate in the survey. They 
were provided with the observational patient’s diary and 
a peak flow meter, and they were trained to take measure-
ments of the peak expiratory flow rate (PEFR) using that 
device.
During the second visit, after 14 days, the patients were 
asked to assess their quality of life using AQLQ. The ques-
tionnaire is designed to be standardized and sufficiently 
sensitive to detect and measure the size of any changes 
in the subjective health in patients with asthma, and it is 
a disease-specific measure of their HRQL.
The questionnaire consists of 32 questions, grouped in 
the following 4 domains of the quality of life:
 – symptoms,
 – limitation of activity,
 – emotional functioning,
 – environmental stimuli.
The patients provided their responses on a 7-degree scale, 
where “7” means no limitation and “1” means a total limita-
tion. The total score of AQLQ is a mean of all 32 responses, 
and the scores in particular domains are the means for posi-
tions which they include. The quality of life was determined 
as a mean of all responses. This result indicated a total score 
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for age (in years), gender, university education (yes vs. no), 
smoking (yes vs. no) and the mean outdoor temperature 
in the measurement period. Among the variables consid-
ered as potential confounders, age, university education 
and temperature in the measurement period were associ-
ated with AQLQ and its domains, in a univariate analysis. 
Gender and smoking were a priori added to the models. 
The potential collinearity between PM10 concentrations 
and temperature was checked using the variance infla-
tion factor (VIF = 1.86), whose values allowed for putting 
those variables into 1 model.
The AQLQ itself was classified into 3 categories, i.e., a good 
quality of life (a score of 6–7), a reduced quality of life 
(a score of 4–5) and a poor quality of life (a score of 1–3), 
where “1” meant good and “3” meant poor. The PM10 ex-
posure level (both as a categorical and continuous variable) 
was used to assess its impact on the poor quality of life using 
ordered logistic regression models adjusted for age, age2, 
gender, university education, active smoking and tempera-
ture in the measurement period. The same analyses were 
conducted for all 4 domains, as 4 separate tests. The pro-
portional odds assumption was verified using the Brant test. 
The term “age2” was added as the age variable did not com-
ply with the proportional odds assumption.
All the tests were 2-tailed, and significance was set at 
p < 0.05. All the analyses were performed using STATA/
IC 13.1 software.
RESULTS
The average PM10 exposure (a mean in the 2-week period) 
was 65.2 μg/m3 (a range of 18.0–128.2 μg/m3) and only 
75 patients (30%) were exposed to values of ≤50 μg/m3, 
i.e., the 24-h threshold recommended by WHO. The PM10 
measurements were equally distributed across seasons. 
There were no significant differences between the patients 
in the number of hours spent outdoors. In general, all 
the patients declared that they spent 2–3 h/day outdoors, 
on average.
The study was conducted with the approval of the Bio-
ethics Committee of the Jagiellonian University 
(No. KBET/167/B/2012).
Statistical analyses
All characteristics were presented as means with standard 
deviations (SD) or frequency with percentage distribution, 
respectively to the measurement scale. Results regarding 
the quality of life of asthma patients (the AQLQ total score 
and its domains) were presented using the median with 
quartile distribution. The 2-week average PM10 concentra-
tions were additionally categorized with cut-offs at 30th 
and 70th percentiles (values of 50 and 80 μg/m3, respec-
tively). The first cut-off at 30th percentile corresponded 
to the 24-h threshold guided by the WHO, while 70th per-
centile of the highest PM10 concentration was selected as 
the second cut-off. In addition, PM10 concentrations were 
analyzed both as continuous and categorical variables. Po-
tential confounders, such as gender, education, smoking, 
employment and keeping pets at home, were controlled in 
the analyses.
Associations between nominal variables were verified 
using the χ2 test or the exact Fisher test, as appropriate. 
Differences in the age of the patients exposed to differ-
ent concentrations of PM10 categories were tested us-
ing one-way ANOVA, whereby the equality of variances 
was verified with Levene’s test and normal distribution in 
subgroups with the Kolmogorov-Smirnov test. Outdoor 
temperature differences across the PM10 categories were 
tested with the Kruskal-Wallis test as the assumption of 
variance homogeneity was not met in ANOVA. The non-
parametric trend in AQLQ scores across the PM10 catego-
ries was also checked [26,27].
The potential impact of airborne PM10 on the quality of 
life of asthma patients (the AQLQ total score and its do-
mains) was estimated in linear regression models with 
2-week average PM10 concentrations, both as categorical 
and continuous variables, with a unit of 10 μg/m3, adjusted 
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Table 2 shows the effects of categorized PM10 expo-
sure on the ARQL adjusted for potential confounders. 
The observed effect of an increased level of exposure 
to airborne PM10 was associated with reduced scores in 
AQLQ from 0.40 at the medium level, as compared to 
the low level, to 0.46 at the high level, as compared to the 
low level. A similar decrease was observed in the symp-
toms and activity limitation domains with differences 
The groups of patients with various average PM10 exposure 
levels did not differ significantly in terms of gender, educa-
tion (university vs. lower), employment or keeping pets at 
home. Nevertheless, the patients exposed to higher levels of 
PM10 were older, and the studied subgroups were significantly 
different in terms of smoking (Table 1). Declining trends in 
the total and specific domains of AQLQ were observed with 
the increasing levels of airborne PM10 exposure (Figure 1).
Table 1. Characteristics of the study group of adult asthma patients over the follow-up period and exposure to PM10 levels,  
Kraków, Poland, 2013–2015
Variable













Gender [n (%)] 0.679a
women 145 (48.3) 42 (46.7) 57 (46.7) 46 (52.3)
men 155 (51.7) 48 (53.3) 65 (53.3) 42 (47.7)
Age [years] (M±SD) 53±15.3 49.5±15.0 52.3±15.3 57.5±14.7 0.002b
Education [n (%)] 127 (42.3) 46 (51.1) 51 (41.8) 30 (34.1) 0.071a
Active smoker [n (%)] 31 (10.3) 3 (3.3) 18 (14.8) 10 (11.4) 0.024a
Current employment [n (%)] 0.247c
student 11 (3.7) 3 (3.3) 7 (5.8) 1 (1.1)
employed 172 (57.5) 58 (64.4) 68 (56.2) 46 (52.3)
unemployed 27 (9.0) 8 (8.9) 12 (9.9) 7 (8)
retired 89 (29.8) 21 (23.3) 34 (28.1) 34 (38.6)
missing 1 (0.3)
Keeping pets at home [n (%)] 133 (43.3) 39 (43.8) 46 (38) 46 (52.3) 0.122a
Temperature [°C] (M±SD) 7.8±5.88 13.8±5.06 6.0±4.47 4.0±2.79 <0.001d
Asthma Quality of Life Questionnaire (Me (Q1–Q3))
total score 5 (4–6) 6 (5–6) 5 (4–6) 5 (3–6) <0.001e
symptoms 6 (4–6) 6 (5–7) 5 (4–6) 5 (3–6) <0.001e
limitation of activity 5 (4–6) 6 (5–6) 5 (4–6) 4.5 (3–5.5) <0.001e
emotional functioning 5 (4–6) 6 (5–6) 5 (4–6) 5 (3–6) <0.001e
environmental stimuli 5 (4–5) 5 (5–6) 4 (4–5) 4 (3–5) <0.001e
a Chi2 test.
b ANOVA.
c Fisher exact test.
d Kruskal-Wallis test.
e Non-parametric test for trend.
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Figure 1. Distribution of a) Asthma Quality of Life Questionnaire (AQLQ) total scores and its domains: b) symptoms, c) limitation of activity, 
d) emotional functioning, e) environmental stimuli according to PM10 levels in adult asthma patients, Kraków, Poland, 2013–2015
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in the symptoms domain. The risk of a poorer quality of 
life in terms of symptoms reached a value that was 3.76 
(95% CI: 1.60–8.90) times higher for the medium level 
of PM10 and 6.77 (95 % CI: 2.56–17.92) for the high lev-
el, compared to the low one. The risk of poor outcomes 
in terms of limitation of activity was 2.81 times higher, in 
emotional functioning 2.37 times higher, and in environ-
mental stimuli 2.45 times higher (95% CI: 1.67–6.26), but 
only in the high vs. low level of the PM10 concentration 
(Table 2).
The effects of the continuously expressed mean of 
the 14-day level of PM10 exposure on ARQL, adjusted for 
potential confounders, are shown in Table 3. All the do-
mains of AQLQ, except environmental stimuli, present-
of 0.51 and 0.46 at the high level of exposure, compared to 
the low level, respectively. In terms of emotional function-
ing and environmental stimuli, the quality of life did not 
differ significantly between the medium and high levels, 
compared to the low level of PM10.
In order to assess the effects of PM10 exposure on the risk 
of poorer outcomes in AQLQ (both total and domains 
scores), multivariable ordinal logistic regression models 
were applied. It was observed that the medium levels of 
PM10 exposure were associated with an over 4-fold higher 
risk of poorer outcomes in AQLQ (OR = 4.29, 95% CI: 
1.94–9.52), while the high exposure with a 6-fold higher 
risk (OR = 6.03, 95% CI: 2.45–14.88), compared to 
the low levels of PM10 exposure. Similar results were seen 
Table 2. Impact of categorized particulate matter 10 (PM10) concentrations on the asthma-related quality of life and the risk  
of a poorer quality of life in the study group of adult asthma patients, Kraków, Poland, 2013–2015
AQLQ and its domains/ 
PM10 levels
Asthma Quality of Life Questionnaire (AQLQ) score
original scale* categorized**
B 95% CI p ORa 95% CI pa
Total score
medium vs. low –0.40 –0.76–(–0.04) 0.030 4.29 1.94–9.52 <0.001
high vs. low –0.46 –0.88–(–0.04) 0.030 6.03 2.45–14.88 <0.001
Symptoms
medium vs. low –0.37 –0.75–0.01 0.054 3.76 1.60–8.90 0.003
high vs. low –0.51 –0.95–(–0.07) 0.023 6.77 2.56–17.92 <0.001
Limitation of activity 
medium vs. low –0.29 –0.67–0.09 0.137 2.11 0.998–4.46 0.051
high vs. low –0.46 –0.90–(–0.02) 0.040 2.81 1.21–6.54 0.016
Emotional functioning
medium vs. low –0.23 –0.68–0.21 0.304 2.02 0.97–4.24 0.061
high vs. low –0.41 –0.93–0.11 0.119 2.37 1.02–5.49 0.045
Environmental stimuli
medium vs. low –0.39 –0.79–0.02 0.063 1.89 0.94–3.79 0.073
high vs. low –0.40 –0.87–0.07 0.097 2.45 1.10–5.47 0.029
B – regression coefficient.
* Linear regression model adjusted to age (years), gender, university education, smoking and temperature in the measurement period.
** Ordered (from “1” – good to “3” – poor) logistic regression model adjusted for age (years), age2, gender, university education, smoking 
and temperature in the measurement period.
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due to primary particles from combustion sources, mainly 
vehicles, with a contribution from secondary particles. 
So, the effects of coarse fractions, such as PM10, cannot 
be excluded, and should be analyzed [30]. There is con-
siderable evidence linking ambient particles measured 
as PM with an aerodynamic diameter of <10 μm (PM10) 
to daily mortality and hospital admissions.
The adverse health impact of PM10 on the human respira-
tory system is well documented by studies showing associa-
tions between the concentrations of PM10 and the quanti-
fied health effects, all cause and cause-specific mortality, 
morbidity and life expectancy, the incidence of respira-
tory diseases, and exacerbation of such diseases [31,32]. 
The overall epidemiological evidence suggests that these 
adverse health effects are dependent on both exposure con-
centrations and the length of exposure, and that long-term 
exposure has stronger and more persistent cumulative ef-
fects than short-term exposure [33]. In the study by Lu et al. 
[34] for a standardized increment in PM with aerodynamic 
diameters of <10 μm (PM10), there is an excessive risk of 
mortality and morbidity in hospitalization. Short-term ex-
posure to PM10 was found to be positively associated with 
increases in mortality for non-accidental causes, cardio-
vascular diseases and respiratory diseases [34]. The study 
by Zhang et al. [35] suggests that short-term exposure to 
outdoor air pollution may induce or exacerbate respiratory 
ed poorer outcomes with the growing concentration of 
PM10 (every 0.08 pt for a 10 μg/m3 increase). The risk of 
a poorer ARQL was increasing with higher PM10 exposure. 
A 10 μg/m3 increase in PM10 was significantly associated 
with a 28% higher risk of poorer total AQLQ (OR = 1.28, 
95 % CI: 1.14–1.44) when adjusted for age, gender, univer-
sity education, smoking and temperature. Similar results 
were observed in each domain, where a 10 μg/m3 increase 
in PM10 raised the risk of poorer outcomes, from 12% in 
emotional functioning to 29% in symptoms (Table 3). Pre-
dicted probabilities of “poor” asthma-related quality of life 
according to PM10 exposure in the total score of AQLQ and 
its domains are presented in Figure 2. As stated, the shad-
owed areas show a 95% CI of the estimated probability.
DISCUSSION
A lower quality of life is an important predictor of hos-
pitalization and mortality among patients with chronic 
obstructive pulmonary disease (COPD) and asthma [28]. 
Coarse PM fractions can lead to adverse responses in 
the lungs, triggering processes leading to hospital admis-
sions [29]. This suggests that special consideration should 
be given to studying and regulating coarse particles sep-
arately from fine particles. Results of the study by An-
derson et al. [30] suggest that the active component of 
PM10 resides mostly in the fine fraction, and this is mostly 
Table 3. Impact of the average 14-day concentrations of PM10 (unit: 10 μg/m3) on the asthma-related quality of life and the risk  
of a poorer quality of life in the study group of adult asthma patients, Kraków, Poland, 2013–2015
AQLQ  
and its domains
Asthma Quality of Life Questionnaire (AQLQ) score
original scale* categorized**
B 95% CI p OR 95% CI p
Total score –0.08 –0.13–(–0.02) 0.010 1.28 1.14–1.44 <0.001
Symptoms –0.08 –0.14–(–0.02) 0.008 1.29 1.14–1.45 <0.001
Limitation of activity –0.08 –0.14–(–0.02) 0.009 1.20 1.07–1.35 0.002
Emotional functioning –0.08 –0.15–(–0.01) 0.029 1.12 1.002–1.26 0.046
Environmental stimuli –0.07 –0.13–(–0.003) 0.060 1.15 1.03–1.29 0.013
Explanations as in Table 2.
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Figure 2. Predicted probabilities (with 95% CI) of a “poor” asthma-related quality of life: a) Asthma Quality of Life Questionnaire 
(AQLQ) total scores and its domains: b) symptoms, c) limitation of activity, d) emotional functioning, e) environmental stimuli, 
according to PM10 levels in adult asthma patients, Kraków, Poland, 2013–2015
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during increased air pollution periods. Physicians may 
have problems with recognizing the reasons, i.e., whether 
these result from media coverage or exposure to air pol-
lution. Popular diagnostic methods that assess the sever-
ity of bronchial asthma and its control, such as spirometry 
and the peak flow meter, do not ensure a full assessment 
of the patients’ health and well-being. There are certain 
health-related tools to measure the quality of life in asth-
ma patients, including sleeping disorders, limitation of 
activity, emotional and mental health problems, anxiety, 
mood swings, and depression symptoms [19,36,37]. Once 
applied in this study, AQLQ proved to be a good stan-
dardized tool, sensitive in detecting changes in subjective 
health, and in measuring asthma-specific problems related 
to the patient’s quality of life [22,23].
The quality of life is an important issue for the contem-
porary understanding and assessment of the health status 
of patients with chronic diseases. Thus, it is important to 
identify and evaluate various factors which interact with 
and impact on their quality of life. The environmental haz-
ards, such as air pollutants, belong to these factors. One of 
the goals in asthma management is to ensure an individual 
patient that the burden of his/her disease is controlled and 
limited, and that the patient is still able to have the best 
possible quality of life. Therefore, taking into consid-
eration the outdoor air quality, including the PM10 con-
centration levels, in planning preventive and educational 
measures addressed to these patients, in order to improve 
their well-being, seems both valuable and useful [19,38].
This study had some methodological limitations regard-
ing the assessment of individual exposure to PM10. The in-
dividual exposure to PM10 was assessed based on records 
for the district of the city which was the closest to the pa-
tient’s place of residence. Mobile dust monitors seem to 
be a more precise method of evaluating PM10 exposure. 
However, due to their technical limitations and difficulties 
in patients’ compliance, the use of mobile dust monitors 
was not possible.
diseases, upper respiratory tract infections, and chronic ob-
structive pulmonary diseases, leading to considerable medi-
cal expenditure of the affected patients.
Despite the above-mentioned epidemiological studies, 
the body of research investigating the influence of air 
pollution, including various concentrations of PM10, on 
the HRQL in asthma patients living in urban areas still 
appears insufficient. This study included an observation 
of the subjective health of patients with asthma, living in 
the urban environment of Kraków, when exposed to vari-
ous concentrations of PM10. The results revealed that in-
creased levels of PM10 were related to a lower quality of 
life in the surveyed patients. The total score of AQLQ and 
the scores for its 4 domains, such as symptoms, limitation 
of activity, emotional functioning and environmental stim-
uli, as assessed in the study, were significantly reduced by 
increasing concentrations of this air pollutant. A decrease 
in HRQL was not only caused by exceeding the highest 
acceptable value of PM10 exposure that was significant, but 
also by the degree of exceeding the norm as well. In situ-
ations where the norm was exceeded multiple times, all 
the domains of the patient’s quality of life showed signifi-
cantly lower scores. Symptoms and limitation of activity 
were the most affected domains of the quality of life, which 
decreased with every single case of exceeding the norm.
An assessment of subjective health in patients suffering 
from asthma has a great value in controlling the course of 
the disease although it is not always appreciated by physi-
cians. The assessment of the patient’s well-being consists not 
only of the observation of symptoms but also of the informa-
tion obtained from the patient concerning his/her quality of 
sleep, limitation of daily activities, and experiencing negative 
emotions related to health threats. Based on the results of 
this research, one can also talk about personal exposure to 
environmental factors, such as dust pollution by PM10 frac-
tions and their impact on the patient’s quality of life.
Patients with asthma often report a considerable deteriora-
tion of their well-being and an intensification of symptoms 
O R I G I N A L  P A P E R       M. ŚCIBOR AND M. MALINOWSKA-CIEŚLIK
IJOMEH 2020;33(3)322
sis.  Energy Policy. 2010;38(9):5059–71, https://doi.org/10.1016/ 
j.enpol.2010.04.034.
5. Dockery DW, Pope CA. Acute Respiratory Effects Of Partic-
ulate Air Pollution. Ann Rev Public Health. 1994;15:107–32, 
https://doi.org/10.1146/annurev.pu.15.050194.000543.
6. Pope CA, Dockery DW, Schwartz J. Review of epidemio-
logical evidence of health effects of particulate air pollu-
tion. Inhal Toxicol. 1995;7:1–18, https://doi.org/10.3109/089 
58379509014267.
7. Li N, Peng XW, Zhang BY. Relationship between air pol-
lutant and daily hospital visits for respiratory diseases 
in Guangzhou: a time-series study. J Environ Health. 
2009;26(12):1077–80.
8. United States Environmental Protection Agency [Internet]. 
Washington, DC: The Agency; 2019 [cited 2019 Jul 1]. Avail-
able from: https://www.epa.gov/pm-pollution.
9. World Health Organization, Occupational and Environ-
mental Health Team [Internet]. Geneva: The Organization; 
2006 [cited 2019 Jul 1]. Air quality guidelines for particulate 
matter, ozone, nitrogen dioxide and sulfur dioxide. Global 
update 2005. Summary of risk assessment. Available from: 
https://apps.who.int/iris/handle/10665/69477.
10. Guarnieri M, Balmes JR. Outdoor air pollution and asthma 
Lancet. 2014;383(9928):1581–92, https://doi.org/10.1016/S0140- 
6736(14)60617-6.
11. Meng YY, Rull RP, Wilhelm M, Lombardi C, Balmes J, Ritz B. 
Outdoor air pollution and uncontrolled asthma in the San 
Joaquin Valley, California. J Epidemiol Community Health. 
2010;64:142–7, https://doi.org/10.1136/jech.2009.083576.
12. Anderson HR, Favarato G, Atkinson RW. Long-term expo-
sure to air pollution and the incidence of asthma: meta-anal-
ysis of cohort studies. Air Qual Atmos Health. 2013;6(1):47–
56, https://doi.org/10.1007/s11869-011-0144-5.
13. Li N, Hao M, Phalen R, Hinds W, Nel A. Particulate air 
pollutants and asthma: A paradigm for the role of oxidative 
stress in PM-induced adverse health effects. Clin Immu-
nol. 2003;109(3):250–65, https://doi.org/10.1016/j.clim.2003. 
08.006.
CONCLUSIONS
The results suggest that in order to attain the manage-
ment goals in asthma treatment, the quality of life should 
be measured next to lung function, especially in the period 
of air pollution and exposure to PM10 in the patient’s place 
of residence and in the surrounding urban environment. 
Brief and short self-administered instruments such as 
AQLQ provide a good opportunity to identify the patients 
at risk, who could benefit more from preventive interven-
tions and patient education.
The study has shown that any exposure to increased val-
ues of PM10 impacts on both the overall quality of life 
and its specific domains among patients with bronchial 
asthma. Being aware that there is no minimal level of 
safe exposure to PM10, physicians should pay special at-
tention to their patients’ quality of life in relation to air 
pollution, especially in places where high or medium 
concentrations of PM10 occur during many days over long 
periods. This should be remembered by both physicians 
and patients.
It seems important to educate patients about the sources 
of air pollutants, such as PM10, factors influencing concen-
tration values, and the possible strategies of reducing their 
individual exposure and susceptibility.
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